-
Something wrong with this record ?
Oxidative stress induced by oxime reactivators of acetylcholinesterase in vitro
L. Muckova, N. Vanova, J. Misik, D. Herman, J. Pejchal, D. Jun,
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Acetylcholinesterase metabolism MeSH
- Hep G2 Cells MeSH
- Humans MeSH
- Oxidative Stress drug effects MeSH
- Oximes pharmacology MeSH
- Cholinesterase Reactivators pharmacology MeSH
- Reactive Nitrogen Species metabolism MeSH
- Reactive Oxygen Species metabolism MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
In this study, we determined the effect of methoxime (MMB-4), asoxime (HI-6), obidoxime (LüH-6), trimedoxime (TMB-4), and pralidoxime (2-PAM) on redox homeostasis in vitro. Cultured human hepatoma cells (HepG2) were exposed to oximes at concentrations equivalent to their IC50 (assessed using MTT assay) and evaluated 1, 4 and 24 h after incubation. Additionally, intact, early and late apoptotic and necrotic cells were quantified by microcapillary flow cytometry. Intracellular levels of oxygen/nitrogen species were determined using two fluorescent probes (2',7'-dichlorodihydrofluorescein diacetate and dihydroethidium). Malondialdehyde and 3-nitrotyrosine were measured by LC-MS/MS. Non-protein thiols and non-protein disulfides were evaluated using HPLC-UV to reflect antioxidant capacity. Oxidative and nitrosative stress was induced by LüH-6, TMB-4 and MMB-4, whereas 2-PAM and HI-6 appeared as weak oxidative stressors with no activity towards nitrosative stress in HepG2 cells. Based on these results, bisquartenary oxime reactivators containing two functional oxime groups at the position 4 of pyridinium ring appear as more intense oxidative and nitrosative inducers. Activation of apoptosis and necrosis do not seem to correlate with generation of RONS. On the other hand, both processes rather reflect MDA concentrations, i.e. the damage of biomolecules.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19011950
- 003
- CZ-PrNML
- 005
- 20190412122811.0
- 007
- ta
- 008
- 190405s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tiv.2019.01.013 $2 doi
- 035 __
- $a (PubMed)30682493
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Muckova, L $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 245 10
- $a Oxidative stress induced by oxime reactivators of acetylcholinesterase in vitro / $c L. Muckova, N. Vanova, J. Misik, D. Herman, J. Pejchal, D. Jun,
- 520 9_
- $a In this study, we determined the effect of methoxime (MMB-4), asoxime (HI-6), obidoxime (LüH-6), trimedoxime (TMB-4), and pralidoxime (2-PAM) on redox homeostasis in vitro. Cultured human hepatoma cells (HepG2) were exposed to oximes at concentrations equivalent to their IC50 (assessed using MTT assay) and evaluated 1, 4 and 24 h after incubation. Additionally, intact, early and late apoptotic and necrotic cells were quantified by microcapillary flow cytometry. Intracellular levels of oxygen/nitrogen species were determined using two fluorescent probes (2',7'-dichlorodihydrofluorescein diacetate and dihydroethidium). Malondialdehyde and 3-nitrotyrosine were measured by LC-MS/MS. Non-protein thiols and non-protein disulfides were evaluated using HPLC-UV to reflect antioxidant capacity. Oxidative and nitrosative stress was induced by LüH-6, TMB-4 and MMB-4, whereas 2-PAM and HI-6 appeared as weak oxidative stressors with no activity towards nitrosative stress in HepG2 cells. Based on these results, bisquartenary oxime reactivators containing two functional oxime groups at the position 4 of pyridinium ring appear as more intense oxidative and nitrosative inducers. Activation of apoptosis and necrosis do not seem to correlate with generation of RONS. On the other hand, both processes rather reflect MDA concentrations, i.e. the damage of biomolecules.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a reaktivátory cholinesterasy $x farmakologie $7 D002801
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a oximy $x farmakologie $7 D010091
- 650 _2
- $a reaktivní formy dusíku $x metabolismus $7 D026361
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vanova, N $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. Electronic address: nela.vanova@unob.cz.
- 700 1_
- $a Misik, J $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 700 1_
- $a Herman, D $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 700 1_
- $a Pejchal, J $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 700 1_
- $a Jun, D $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
- 773 0_
- $w MED00004536 $t Toxicology in vitro an international journal published in association with BIBRA $x 1879-3177 $g Roč. 56, č. - (2019), s. 110-117
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30682493 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190412122830 $b ABA008
- 999 __
- $a ok $b bmc $g 1391260 $s 1050255
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 56 $c - $d 110-117 $e 20190123 $i 1879-3177 $m Toxicology in vitro $n Toxicol In Vitro $x MED00004536
- LZP __
- $a Pubmed-20190405